BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/30/2024 10:05:55 AM | Browse: 74 | Download: 590
 |
Received |
|
2024-07-17 17:16 |
|
Peer-Review Started |
|
2024-07-17 17:16 |
|
First Decision by Editorial Office Director |
|
2024-08-05 21:16 |
|
Return for Revision |
|
2024-08-06 11:37 |
|
Revised |
|
2024-09-09 12:37 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-11 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-11 09:16 |
|
Articles in Press |
|
2024-10-11 09:16 |
|
Edit the Manuscript by Language Editor |
|
2024-10-16 14:58 |
|
Typeset the Manuscript |
|
2024-10-28 08:53 |
|
Publish the Manuscript Online |
|
2024-10-30 10:05 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Proton pump inhibitors and all-cause mortality risk among cancer patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arunkumar Krishnan, Carolin Victoria Schneider and Declan Walsh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arunkumar Krishnan, MD, Assistant Professor, Department of Supportive Oncology, Atrium Health Levine Cancer, 1021 Morehead Medical Drive, Suite 70100, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com |
| Key Words |
Outcome; Carcinoma; Proton pump inhibitors; Malignancy; Mortality; Histamine-2 receptor antagonists; Cancer; All-cause mortality |
| Core Tip |
Proton pump inhibitors (PPIs) are commonly used medications. Recent studies have raised concerns regarding increased all-cause and cause-specific mortality with PPIs. However, limited studies have addressed this issue in cancer patients. In addition, an association between PPI and the mortality risk in unselected cancer populations remains uncertain. We investigated the association between PPI use and all-cause mortality in patients diagnosed with cancer. PPI use among cancer patients was associated with a higher risk of all-cause mortality compared to non-users or histamine-2 receptor antagonist users. These results strongly suggest the need for cautious use of PPIs in cancer patients and suggest that alternative treatments should be considered when clinically feasible. |
| Publish Date |
2024-10-30 10:05 |
| Citation |
Krishnan A, Schneider CV, Walsh D. Proton pump inhibitors and all-cause mortality risk among cancer patients. World J Clin Oncol 2025; 16(1): 99240 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i1/99240.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i1.99240 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
